Skip to textbook content
Doctor’s PassportTextbook
TopicsAll topics

Loading topic navigation…

Textbook navigation
TopicsAll topics

Loading topic navigation…

Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.

Recognising dying

Palliative and end-of-life care · UK scope · Sources checked 27 Aug 2026 · Clinical review pending

RapidFull
!
Unexpected deterioration during possible dying

A person thought to be dying may instead have hypoglycaemia, opioid toxicity, urinary retention, sepsis, haemorrhage, spinal compression or another reversible emergency. A sudden change inconsistent with the trajectory requires prompt reassessment.

Action: Use a proportionate ABCDE and bedside glucose assessment, review recent medicines and examine for pain, retention, impaction, bleeding and focal neurological or infective signs. Treat immediately reversible distress within the agreed ceiling, seek senior review and revise the last-days plan if recovery remains plausible.

Synopsis

Recognise when a person may be entering the last days, test proportionate reversible explanations, communicate uncertainty honestly and replace burdensome routine care with an individual symptom, family, spiritual and practical plan that remains under review.

  • Dying is a clinical judgement based on trajectory, disease, function and a cluster of signs; no single observation, score or test proves that death is imminent.
  • Common changes include becoming bedbound, profound weakness, reduced desire or ability to eat and drink, increasing sleep, reduced urine, altered breathing and peripheral cooling.
  • First-line review asks whether infection, hypercalcaemia, medicine toxicity, hypoglycaemia, retention, constipation, bleeding or another reversible problem explains the change and whether treating it matches the person's goals.
  • Use senior multidisciplinary assessment and repeat it when uncertainty remains. Document ‘may be dying’ rather than presenting an uncertain prediction as certainty.
  • Tell the person, if they wish to know, and those important to them that time may be short; explain what changes may occur, what the team will do and whom to contact.
  • Review medicines, observations, blood tests, oxygen, fluids, nutrition, devices and care setting individually; stop interventions whose burden now exceeds likely benefit.
  • Prescribe anticipatory medicines for pain, breathlessness, agitation, nausea and respiratory secretions with a clear route, dose, indication and escalation plan.
  • Frequent mouth care, comfortable positioning, pressure protection, bladder and bowel attention and calm presence remain active clinical care even when intake falls.
  • Explore cultural, spiritual, religious and family needs, preferred visitors, rituals, privacy and place of care without making assumptions from identity.
  • Reassess at least daily and whenever the condition changes; people can stabilise, and the last-days plan must be revised if the trajectory no longer fits.

Key red flags

Abrupt reduced consciousness after opioid escalation or kidney decline suggests toxicity rather than inevitable dying.

New focal weakness, severe back pain or sphincter dysfunction requires the MSCC or stroke pathway when treatment remains wanted.

Active major bleeding, stridor, seizure or uncontrolled pain needs an emergency response even under a comfort-focused plan.

A distended bladder, painful abdomen or overflow can cause severe agitation and is often rapidly treatable.

Hypoglycaemia should be checked promptly in diabetes, poor intake, insulin use or unexplained sudden drowsiness.

Family reports of an abrupt change from a stable baseline should be taken seriously even if observations appear only mildly abnormal.

Conflict about diagnosis, information or treatment should prompt senior and specialist review, not withdrawal from communication.

Unexpected acute deterioration

Abrupt collapse, severe new pain, bleeding, hypoglycaemia or medicine toxicity may be reversible and requires immediate goal-based assessment rather than automatic dying diagnosis.

Investigation priorities

01
First-line trajectory assessmentFirst stepFirst line

Compare mobility, self-care, wakefulness, intake, swallowing, urine, symptoms and treatment response over recent days and weeks.

02
Communication and plan auditPreferred

Confirm who has been told, information preferences, escalation, preferred place, anticipatory medicines and cultural or spiritual needs.

Management branches

RecognitionSynthesize trajectory and reversible causes

A person with advanced illness shows progressive functional, intake, consciousness, circulation or breathing change.

  1. Compare the current state with recent baseline and seek nursing, family and disease-team observations, then assess symptom burden and immediate safety.
  2. Check proportionate reversible explanations such as glucose, medicines, retention, constipation, infection, calcium and bleeding according to goals.
  3. Seek senior multidisciplinary agreement, document evidence and uncertainty and state when the diagnosis and treatment plan will be reviewed.
Individual planReplace low-value routine with comfort-focused care

The person is likely in the last days and the plan prioritises comfort and chosen relationships.

  1. Review every medicine, observation, test, device, oxygen, antimicrobial, fluid and nutrition intervention for short-term benefit, burden and withdrawal risk.
  2. Provide anticipatory symptom prescriptions with a feasible route and continue essential comfort or withdrawal-prevention treatment, plus mouth, skin, bladder and bowel care.
  3. Coordinate staffing, equipment, family support, overnight access, place of care and care-after-death preferences across all involved services.
Open full textbook →Answer 2 questions
Sources and review status4 sources · checked 27 Aug 2026 · clinical review pending+
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Apply principles in context and verify current guidance when a decision affects care. Source check completed 27 Aug 2026; clinical approval remains outstanding.

  • NICE NG31 care of dying adultsRecognition, communication, reversible causes, hydration and individualised last-days care.
  • Scottish Palliative Care Guidelines last daysClinical signs, medicine review, symptom care, family communication and care after death.
  • NICE NG142 end-of-life service deliveryCoordination, access, preferred place, specialist support and carer needs.
  • GMC end-of-life treatment guidanceCommunication, uncertainty, capacity and review of potentially burdensome treatment.

Editorial contact: Doctor’s Passport editorial team. Source-check date is separate from clinical approval. Report a content problem · Content changes

Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom